Document Detail


Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis.
MedLine Citation:
PMID:  19151047     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
While conventional practice is to discontinue aspirin prior to elective cardiac surgery there is evidence that its continuation may be associated with improved perioperative outcomes. However, uncertainty exists regarding the efficacy of antifibrinolytic agents in the presence of aspirin. We performed a systematic review and meta-analysis of the literature to address the question of the effects of antifibrinolytic agents in cardiac surgery patients maintained on aspirin in terms of both efficacy and adverse events. We conducted an extensive search for randomized controlled trials of antifibrinolytic use in adult patients undergoing coronary artery bypass grafting +/- valve surgery, where aspirin therapy was maintained or initiated through the preoperative period. Data from 17 trials (n=1620) confirmed the efficacy of antifibrinolytic therapy to reduce both chest-tube drainage (weighted mean difference 374 ml, 95% CI 275-473 ml; P<0.00001) and blood transfusion requirements (odds ratio 0.37, 95% CI 0.27-0.49; P<0.00001) in cardiac surgical patients receiving aspirin. We found no difference in the rates of adverse events between groups but observed a trend towards a reduced risk for the composite outcome of thrombotic complications (odds ratio 0.49, 95% CI 0.21-1.13; P=0.09). Antifibrinolytic agents are effective for reducing both chest-tube drainage and transfusion requirements in cardiac surgical patients receiving aspirin. We found no difference between antifibrinolytic and placebo in terms of adverse events but the population was predominantly low-risk. Further studies are required to determine the optimal balance between antiplatelet and antifibrinolytic effects in cardiac surgery.
Authors:
D R McIlroy; P S Myles; L E Phillips; J A Smith
Related Documents :
682687 - Effect of aspirin on prevention of coronary and cerebrovascular disease in patients wit...
1455187 - Gastric changes in coronary-operated patients with low-dose aspirin.
17340057 - High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin ...
11412247 - Systematic review of antiplatelet therapy for the prevention of myocardial infarction, ...
10639307 - Serum troponins t and i after elective cardioversion.
22209947 - Electrocardiographic characteristics of patients with false tendon: possible associatio...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  British journal of anaesthesia     Volume:  102     ISSN:  1471-6771     ISO Abbreviation:  Br J Anaesth     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-19     Completed Date:  2009-02-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372541     Medline TA:  Br J Anaesth     Country:  England    
Other Details:
Languages:  eng     Pagination:  168-78     Citation Subset:  IM    
Affiliation:
Department of Anaesthesia & Perioperative Medicine, Alfred Hospital, Commercial Road, Melbourne, Victoria 3004, Australia. dm2655@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antifibrinolytic Agents / adverse effects,  therapeutic use*
Aspirin / adverse effects,  therapeutic use*
Blood Transfusion
Cardiac Surgical Procedures*
Chest Tubes
Drainage
Drug Interactions
Humans
Perioperative Care / methods*
Platelet Aggregation Inhibitors / adverse effects,  therapeutic use*
Randomized Controlled Trials as Topic
Respiratory Insufficiency / chemically induced
Chemical
Reg. No./Substance:
0/Antifibrinolytic Agents; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Benefit and risk of intrathecal morphine without local anaesthetic in patients undergoing major surg...
Next Document:  Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft sur...